August 11, 2025
Vinay Prasad, MD, MPH, returned to his role as director of the Center for Biologics Evaluation and Research (CBER) 12 days after his departure. Endpoints News first reported Prasad’s return. A spokesperson from the U.S. Department of Health and Human Services confirmed to Reuters that his reinstatement came at the request of FDA Commissioner Marty Makary.